alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Clinical trials

Clinical trials

Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.

If you are thinking about joining a trial

A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.

Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.

Clear filters Download all 7,816 as CSV

"Open to new participants" means the registry status is RECRUITING or NOT_YET_RECRUITING — 1,523 of the 7,816 records. That is what the sponsor last told the registry, which can be months out of date.
Location is by country. This pull of the registry records the countries a study runs in, not its individual sites, so we cannot filter by US state or city — and we are not going to guess one. To find the nearest site, open a trial's record below: the official page lists every location with its contact details.

Showing 6,276–6,300 of 7,816 matching trials · page 252 of 313, 25 per page.

Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.

Registered Alzheimer's clinical trials. Every ID links to its official ClinicalTrials.gov record.
Trial Phase Status Enrolled Sponsor Last updated
PET Imaging of Brain Amyloid Using [11C]MeS-IMPY
NCT00407576
[11C]MeS-IMPY
Runs in: United States · 1 site 		PHASE1
other		 COMPLETED 30 National Institute of Mental Health (NIMH)
NIH		 2017-07-02
MRI of Alzheimer's Disease Imaging Amyloid Plaques in Persons With and Without Memory Problems
NCT00413621
Runs in: United States · 2 sites 		NA
other		 COMPLETED 40 National Institute of Neurological Disorders and Stroke (NINDS)
NIH		 2017-07-02
Making Sense of a Positive Genetic Test Result for Huntington Disease
NCT00539747
Runs in: United States · 4 sites 		NA
other		 COMPLETED 50 National Human Genome Research Institute (NHGRI)
NIH		 2017-07-02
Effects of a Combined Transcranial Magnetic Stimulation (TMS) and Cognitive Training in Alzheimer Patients
NCT01504958
Repetitive Transcranial Magnetic Stimulation (rTMS); NICE Cognitive...
Runs in: United States · 1 site 		NA
other		 COMPLETED 22 Beth Israel Deaconess Medical Center
OTHER		 2017-07-02
Deep Brain Stimulation for Treatment of Severe Alzheimer's Disease
NCT03115814
Runs in: China · 1 site 		NA
other		 UNKNOWN 6 Chinese PLA General Hospital
OTHER		 2017-07-02
Brain Uptake of GSK1034702: a Positron Emission Tomography (PET) Scan Study
NCT00937846
GSK1034702
Runs in: United Kingdom · 2 sites 		PHASE1
other		 COMPLETED 4 GlaxoSmithKline
INDUSTRY		 2017-06-27
Cognitive Intervention in Mild Cognitive Impairment With or Without White Matter Hyperintensities
NCT03195803
Computerized Cognitive Stimulation 		NA
other		 COMPLETED 51 Leila DJABELKHIR
OTHER		 2017-06-22
A Computer-based Cognitive Stimulation in Mild Cognitive Impairment With White Matter Hyperintensities
NCT03195816
Computerized Cognitive training 		NA
other		 UNKNOWN 90 Leila DJABELKHIR
OTHER		 2017-06-22
Feasibility Study of a Computerized Cognitive Stimulation
NCT03195829
Computerized Cognitive Stimulation; Multimedia-based internet 		NA
other		 COMPLETED 20 Leila DJABELKHIR
OTHER		 2017-06-22
Healthy Volunteer Positron Emission Tomography (PET) Brain Occupancy Study of a Phosphodiesterase 4 (PDE4) Inhibitor in Huntington's Disease
NCT01602900
GSK356278; Rolipram
Runs in: United Kingdom · 2 sites 		PHASE1
other		 COMPLETED 8 GlaxoSmithKline
INDUSTRY		 2017-06-20
Phase I, Healthy Subject, Safety, Tolerability and Pharmacokinetic Study of an M1 Agonist to Treat Cognitive Impairment
NCT02291783
HTL0009936; HTL0009936 placebo
Runs in: United Kingdom · 1 site 		PHASE1
other		 COMPLETED 108 Nxera Pharma UK Limited
INDUSTRY		 2017-06-20
A Study of Low-level Light Therapy Using Photo-activated Modulation Ameliorates Cognitive Deficits
NCT03192670
Low-level light therapy device
Runs in: South Korea · 2 sites 		NA
other		 UNKNOWN 168 Yong-il Shin, MD
OTHER		 2017-06-20
Serotonergic Pharmacotherapy for Agitation of Dementia
NCT00009204
Citalopram [Celexa]; Perphenazine [Trilafon]
Runs in: United States · 1 site 		PHASE3
other		 COMPLETED — Bruce Pollock
OTHER		 2017-06-16
A 3 Year Study to Evaluate the Safety and Efficacy of Low Dose Ladostigil in Patients With Mild Cognitive Impairment
NCT01429623
ladostigil hemitartrate; Placebo
Runs in: Austria; Germany; Israel · 12 sites 		PHASE2
other		 COMPLETED 210 Avraham Pharmaceuticals Ltd
INDUSTRY		 2017-06-15
A Repeat Dose Study in Healthy Volunteers Investigating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK356278
NCT01573819
GSK356278; Placebo
Runs in: Netherlands · 1 site 		PHASE1
other		 COMPLETED 36 GlaxoSmithKline
INDUSTRY		 2017-06-15
Effects of Preoperative Using of Eye Patches on Prevention of Emergence Agitation After Cataract Surgery
NCT02590744
eye patch; non-eye patch
Runs in: China · 1 site 		NA
other		 UNKNOWN 180 Xiaoliang Gan
OTHER		 2017-06-15
Treatment With Namenda in Women at Risk for Cognitive Decline
NCT00242632
Namenda
Runs in: United States · 1 site 		NA
other		 COMPLETED 22 Stanford University
OTHER		 2017-06-14
Modulation of Abeta Levels by GSK933776 in Alzheimer's Disease Patient
NCT01424436
GSK933776; GSK933776; GSK933776
Runs in: Germany; Sweden · 7 sites 		PHASE1
other		 COMPLETED 19 GlaxoSmithKline
INDUSTRY		 2017-06-14
Randomized Controlled Trial of Dexmedetomidine for the Treatment of Intensive Care Unit (ICU) Delirium
NCT00351299
Dexmedetomidine; Standard of Care
Runs in: United States · 1 site 		PHASE2
other		 COMPLETED 53 Brigham and Women's Hospital
OTHER		 2017-06-09
Study of Paroxetine and Fluconazole for the Treatment of HIV Associated Neurocognitive Disorder
NCT01354314
Fluconazole; Paroxetine; Paroxetine and Fluconazole; Placebo
Runs in: United States · 1 site 		PHASE1|PHASE2
other		 COMPLETED 45 Johns Hopkins University
OTHER		 2017-06-09
GSK2647544 RD, DDI in Healthy Young and Elderly Volunteers
NCT01978327
GSK2647544; drug-drug interaction
Runs in: United Kingdom · 1 site 		PHASE1
other		 TERMINATED 12 GlaxoSmithKline
INDUSTRY		 2017-06-08
A Study to Evaluate the Pharmacokinetics of E2609 and Its Metabolites in Subjects With Mild and Moderate Hepatic Impairment Compared With Healthy Subjects
NCT02859207
E2609
Runs in: United States · 3 sites 		PHASE1
other		 COMPLETED 32 Eisai Inc.
INDUSTRY		 2017-06-08
Comparison of PET Amyloid Imaging in Japanese and Western Subjects
NCT02813070
[18F] Flutemetamol 		PHASE2
other		 COMPLETED 70 GE Healthcare
INDUSTRY		 2017-06-05
Verification Study and Reactivity Study for the Validity of QuQu Scale
NCT02667665
Runs in: Japan · 1 site 		NA
other		 COMPLETED 240 Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
OTHER		 2017-06-02
Study Evaluating The Long-Term Safety And Efficacy Of Subcutaneous Bapineuzumab
NCT00916617
bapineuzumab
Runs in: United States · 16 sites 		PHASE2
anti-amyloid-antibody		 TERMINATED 62 Pfizer
INDUSTRY		 2017-06-01

This table is wider than a phone screen — swipe it sideways to see the rest.

Where these trials come from

Registry
ClinicalTrials.gov, pulled through their public API (v2)
Trials in the file
7,816
Source file
trials.csv (3.8 MB, 7816 rows)
Basis
Measured These are registry records as submitted by each study's sponsor.

What could make this misleading

Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.

Always check the official record before acting on anything here. This is a summary, not medical advice.

Related evidence Treatments → What the drugs that finished their trials actually achieved.

From the research library

The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.

Clinical trials

All 162 studies on Clinical trials →